Images in this collection

April 14, 2020, Chelsea, Massachusetts,USA: The BioMedomics Rapid IgM-IgG Combined Antibody Test for COVID-19 at rapid blood fingerstick study site. The study, study is sponsored by Partners Health Care, not-for-profit health care system, is to measure the prevalence of COVID-19 in Chelase, Massacusetts. Chelsea leaders said on March 9, that Chelsea currently has a higher rate of infection than New York City. More than 60% of residents of Chelsea are Latino, and almost half are immigrants. (125344558)

April 14, 2020, Chelsea, Massachusetts,USA: The BioMedomics Rapid IgM-IgG Combined Antibody Test for COVID-19 at rapid blood fingerstick study site. The study, study is sponsored by Partners Health Care, not-for-profit health care system, is to measure the prevalence of COVID-19 in Chelase, Massacusetts. Chelsea leaders said on March 9, that Chelsea currently has a higher rate of infection than New York City. More than 60% of residents of Chelsea are Latino, and almost half are immigrants. (125344561)